FDA approves new blood test for Alzheimer’s disease
The Food and Drug Administration (FDA) has granted approval for a new test for Alzheimer's disease, marking the fourth time such a blood test has been approved in less than two years. Roche announced Sunday that the FDA had granted approval to its Elecsys Phospho-Tau blood test for diagnosing Alzheimer's disease. It's the fourth such...
Covered in this story
Summary aggregated from The Hill's public RSS feed. The full reporting belongs to The Hill — please read it on their site.